SLC2A1 and neoplasm: It is a synthetic small inhibitory molecule that serves as an effective pan-Class I GLUT inhibitor both in vitro and in vivo in cancer cells. It can bind to GLUT1-4 in the outward-open conformation, suppressing tumor growth by inhibiting GLUT1-4-mediated glucose transport and metabolism